J Korean Ophthalmol Soc > Volume 54(5); 2013 > Article
Journal of the Korean Ophthalmological Society 2013;54(5):757-765.
DOI: https://doi.org/10.3341/jkos.2013.54.5.757    Published online May 15, 2013.
Long-Term Results of Ahmed Valve Implantation in Neovascular Glaucoma and the Effects of Intracameral Bevacizumab.
Jong Jin Kim, Jae Pil Shin
Department of Ophthalmology, Kyungpook National University School of Medicine, Daegu, Korea. Jps11@hanmail.net
신생혈관녹내장에서 아메드밸브삽입술의 장기 결과와 베바시주맙의 전방내 주사 효과
김종진⋅신재필
Department of Ophthalmology, Kyungpook National University School of Medicine, Daegu, Korea
Abstract
PURPOSE
To evaluate the long-term surgical results of Ahmed glaucoma valve implantation (AGVI) and the effects of intracameral bevacizumab injection in neovascular glaucoma (NVG) after diabetic vitrectomy. METHODS: We reviewed the medical records of 57 patients with NVG after diabetic vitrectomy who underwent AGVI with or without intracameral bevacizumab injection. In each group, preoperative and postoperative intraocular pressure, the number of glaucoma medications, and best corrected visual acuity (BCVA) were compared. We analyzed the rates of surgical success, postoperative complications, and risk factors. RESULTS: The cumulative probability of success was 87.7% at 1 year, 78.8% at 2 years, 70.5% at 3 years, and 61.6% at 5 years. Intraocular pressure and the number of glaucoma medications were significantly reduced and BCVA was significantly better at all postoperative follow-up time points in both groups. There were no differences in mean intraocular pressure, the number of glaucoma medications, BCVA, or the rates of surgical success between the two groups. The incidence of hypertensive phase was significantly reduced in the intracameral bevacizumab group, but neither the surgical success rate nor intraocular pressures were different compared with the control group. CONCLUSIONS: Ahmed glaucoma valve was a good therapeutic modality for long-term treatment of NVG occuring after diabetic vitrectomy. Intracameral bevacizumab injection had no effects on the surgical results of Ahmed glaucoma valve surgery.
Key Words: Ahmed glaucoma valve implantation;Bevacizumab;Diabetic vitrectomy;Neovascular glaucoma


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next